Yazenthe healthcare company specialising in the comprehensive treatment of obesity through its digital platform, today announced the launch of the 19.5 million oversubscribed Series A financing round closes. The company, a pioneer in a multidisciplinary approach integrating doctors, health coaches, psychologists, nutritionists and personal trainers, and supported by innovative medical treatments, will strengthen its position as a pioneer in the treatment of obesity and reinforce its international expansion plans with this financial backing.
The financing round was co-led by Evli Growth Partners (Finland) and Helsana HealthInvest (Switzerland), with participation from Almaz Capital (Germany) and Yabeo (Germany). Yazen is also supported in this financing round by Swedish investors Luminar Ventures and Aggregate Media.
The Obesity is one of the world's most widespread health problems.
It is estimated that by 2035 the prevalence of obesity in Spain will affect 37% of the population according to figures from the World Obesity Federation. For this reason, Yazen has developed a comprehensive model that can have a lasting impact on patients with obesity. Combining multidisciplinary care to introduce lifestyle changes with modern medicine, Yazen has already helped more than 20,000 patients in Sweden, with a high retention rate of 70% after one year. The company is already profitable in the Swedish market and now expects to accelerate its growth.
The new funding will further scale the business internationally. Following its success in Sweden and the launch of Germany and the UK as pilot markets, Yazen is now aiming to expand into Spain, Norway and the Netherlands. The company has ambitious plans to triple its growth in the next 2-3 years, focusing on improving its offering, strengthening the organisation and expanding in these countries, with the aim of helping to make the world a healthier place.
Spain is a key country in the fight against obesity, as currently 63.7% of men and 48.4% of women are overweight, while obesity affects 19.3% of men and 18% of women, according to recent data from the Spanish Society for the Study of Obesity (SEEDO). These ever-increasing figures require a comprehensive approach to reduce the prevalence of obesity through effective and sustainable solutions, ranging from prevention to innovative treatments.
Developing services and implementation for the benefit of patients
The investment will also enable further development of the Yazen app and its integrated care service, designed to better support patients on their journey to a healthier life. Yazen offers a multidisciplinary care model where patients are supported by a specialised team of doctors, coaches, psychologists, dieticians and personal trainers, providing a complete solution that is reflected in the excellent feedback and engagement of users. It's not just the medication that makes the difference; it's the collaborative approach of the entire Yazen team that helps patients to patients.
New chairman of the board from Rovio company
As a result of the financing round, Yazen welcomes Mikael Hed, founding partner of Evli Growth Partners and former CEO of Rovio (creators of Angry Birds), as the new Chairman of the Board. His experience in building and scaling an international brand will be a highly valuable asset for Yazen in its next phase of growth.
"We are very proud of what we have achieved so far and the strong growth we have experienced in Sweden. This funding gives us the opportunity to continue our mission to fight obesity on a global scale. With Mikael Hed as our new chairman and the support of our new investors, we are better positioned than ever to make a difference," explained Fredrik Meurling, CEO and founder of Yazen.
"Yazen's integrated offering has quickly demonstrated an impressive track record. I look forward to leading the work of the board and, together with existing and new investors, continuing Yazen's international expansion," said Mikael Hed, Growth Partner at Evli Growth Partners.
